Ad
related to: BioNTech and Pfizer
Search results
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 23 hours agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 2 hours agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...
What's Going On With Pfizer Stock On Thursday? - GSK (NYSE:GSK), Pfizer (NYSE:PFE)
Benzinga· 7 days agoGSK Plc GSK has reportedly taken legal action against Pfizer Inc PFE and BioNTech SE BNTX in a...
TIME100 Health: Katalin Kariko and Drew Weissman
Time via AOL· 5 hours agoIn under a year, both Pfizer-BioNTech and Moderna developed mRNA-based COVID-19 vaccines based on Kariko and Weissman’s method. The shots helped to slow...
TIME100 Health: Katalin Kariko and Drew Weissman
Time Magazine· 5 hours agoDr. Drew Weissman was working on developing an HIV vaccine, and Katalin Kariko was struggling to keep her lab open and convince her superiors that her...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 4 hours agoLitigation and Intellectual Property Updates Arbutus continues to defend its intellectual property vigorously, particularly in ongoing litigation with Moderna and Pfizer/& ...
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle -...
Benzinga· 6 days agoCanadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV CVAC have settled...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Fina
Guru Focus· 4 hours agoRevenue: Reported at $1.5 million for Q1 2024, a significant decrease from $6.7 million in Q1 2023, falling short of the estimated $2.15 million.Net Loss: Reco
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights
Reuters· 7 days agoBiotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 7 days agoAfter hitting a two-year high in February, biotech stocks have pulled back markedly in April. In...